About Xaa-Pro dipeptidase
Xaa-Pro dipeptidase (PEPD) is a protein
from Homo sapiens identified by UniProt accession
P12955, 493 residues long.
MolForge cross-references it against 0 known binders and
410 disease associations.
Target properties
| Protein name | Xaa-Pro dipeptidase |
| UniProt accession | P12955 |
| Gene | PEPD |
| Organism | Homo sapiens |
| Length | 493 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (410)
Diseases linked to this target (Open Targets).
- prolidase deficiency · score 0.82
- body fat percentage · score 0.46
- high density lipoprotein cholesterol measurement · score 0.45
- sex hormone-binding globulin measurement · score 0.43
- body mass index · score 0.42
- aspartate aminotransferase measurement · score 0.41
- serum alanine aminotransferase measurement · score 0.40
- systolic blood pressure · score 0.39
- appendicular lean mass · score 0.39
- fat body mass · score 0.38
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P12955-F1 | alphafold | PREDICTED | 97.43 | — |
Amino-acid sequence (493 residues)
MAAATGPSFW LGNETLKVPL ALFALNRQRL CERLRKNPAV QAGSIVVLQG GEETQRYCTD TGVLFRQESF FHWAFGVTEP GCYGVIDVDT GKSTLFVPRL PASHATWMGK IHSKEHFKEK YAVDDVQYVD EIASVLTSQK PSVLLTLRGV NTDSGSVCRE ASFDGISKFE VNNTILHPEI VECRVFKTDM ELEVLRYTNK ISSEAHREVM KAVKVGMKEY ELESLFEHYC YSRGGMRHSS YTCICGSGEN SAVLHYGHAG APNDRTIQNG DMCLFDMGGE YYCFASDITC SFPANGKFTA DQKAVYEAVL RSSRAVMGAM KPGVWWPDMH RLADRIHLEE LAHMGILSGS VDAMVQAHLG AVFMPHGLGH FLGIDVHDVG GYPEGVERID EPGLRSLRTA RHLQPGMVLT VEPGIYFIDH LLDEALADPA RASFLNREVL QRFRGFGGVR IEEDVVVTDS GIELLTCVPR TVEEIEACMA GCDKAFTPFS GPK
Explore Xaa-Pro dipeptidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets